SEC Filing Update: #ENGN enGene Therapeutics Inc. : $1.71

Sector: Healthcare | YTD: 🔽 -80.76% The SEC disclosed Today (13-AUG-2026) that Invus Global Management, LLC has INCREASED #ENGN Shares by 4.36% 🟢 * Previous Holdings: 5.25M Shares * Current Holdings: 5.48M Shares * Increase+228.82K * Increased(%)+4.36% * Ownership: 8.2% * Estimated Investment Value: $405.02K https://www.thinksabio.com/reports/isr/ENGN 📌 Institutional activity in the last 30 days for #ENGN: • ACORN BIOVENTURES, L.P.  – Newly bought 1,410,059 shares (22-JUL-2026)